Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Essa Pharma (EPIX)

Essa Pharma (EPIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 78,900
  • Shares Outstanding, K 20,762
  • Annual Sales, $ 0 K
  • Annual Income, $ -10,440 K
  • 60-Month Beta 1.75
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.20
  • Number of Estimates 3
  • High Estimate -0.16
  • Low Estimate -0.24
  • Prior Year -0.54
  • Growth Rate Est. (year over year) +62.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.00 +30.67%
on 03/19/20
5.04 -22.22%
on 03/03/20
-1.15 (-22.68%)
since 03/02/20
3-Month
3.00 +30.67%
on 03/19/20
5.94 -34.01%
on 01/15/20
-1.60 (-28.99%)
since 01/02/20
52-Week
1.41 +178.01%
on 08/05/19
6.14 -36.13%
on 12/13/19
+0.35 (+9.80%)
since 04/02/19

Most Recent Stories

More News
Solebury Trout Announces Virtual Conference Series with Presentations from Life Science Companies

NEW YORK, NY / ACCESSWIRE / March 24, 2020 / Solebury Trout, a boutique investor relations and corporate communications firm, announced today that it will be hosting a Virtual Conference Series on March...

AFMD : 1.6400 (+3.14%)
APM : 3.13 (-18.91%)
CATB : 3.83 (-0.78%)
EPIX : 3.80 (+0.26%)
EVFM : 4.91 (-4.84%)
PIRS : 2.12 (+2.91%)
SLGL : 6.49 (+0.78%)
ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders

ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX, TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, is pleased to announce the results...

EPI.VN : 5.360 (-7.59%)
EPIX : 3.80 (+0.26%)
Janpix, Inc. Announces Appointment of Sanford (Sandy) Zweifach as Executive Chairman to its Board of Directors

-Addition of Experienced Executive to Leadership Team-

CGEN : 7.24 (+3.87%)
EPIX : 3.80 (+0.26%)
Encode Ideas, L.P. Announces the Initiation of Research Coverage on ESSA Pharma, Inc.

Dover, Delaware--(Newsfile Corp. - November 11, 2019) - Encode Ideas, L.P. Initiates Research on ESSA Pharma, Inc. (NASDAQ: EPIX). The full research publication is available and available on our website...

EPI.TO : 0.32 (-3.03%)
EPIX : 3.80 (+0.26%)
Palladio Biosciences Appoints Marella Thorell Chief Financial Officer

Palladio Biosciences, Inc. (Palladio) http://palladiobio.com/, a privately-owned, clinical stage biopharmaceutical company developing medicines for orphan diseases of the kidney, announced today the appointment...

RLM : 2.50 (-0.40%)
EPIX : 3.80 (+0.26%)
CPB : 47.48 (+3.26%)
ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress

ESSA Pharma Inc. (Nasdaq: EPIX) (TSXV: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today presented new preclinical data on ESSA's lead Investigational...

EPIX : 3.80 (+0.26%)
EPI.VN : 5.360 (-7.59%)
ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress

ESSA Pharma Inc. (Nasdaq: EPIX) (TSXV: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today presented new preclinical data on ESSA's lead Investigational...

EPIX : 3.80 (+0.26%)
EPI.VN : 5.360 (-7.59%)
Factors of Influence in 2019, Key Indicators and Opportunity within Berry Global Group, Tuniu, Avista, Information Services Group, ESSA Pharma, and CPS Technologies -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Berry Global Group, Inc. (NYSE:BERY),...

BERY : 33.78 (+2.12%)
TOUR : 1.0200 (-0.98%)
AVA : 41.74 (+5.70%)
III : 1.90 (-11.63%)
EPIX : 3.80 (+0.26%)
CPSH : 0.9900 (+4.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Trade EPIX with:

Business Summary

ESSA Pharma Inc. is a pharmaceutical company. The company focused on the development of small molecule drugs for the treatment of cancer, with focus on advanced prostate cancer. ESSA Pharma Inc. is based in Vancouver, Canada.

See More

Key Turning Points

2nd Resistance Point 4.06
1st Resistance Point 3.93
Last Price 3.80
1st Support Level 3.64
2nd Support Level 3.47

See More

52-Week High 6.14
Fibonacci 61.8% 4.33
Last Price 3.80
Fibonacci 50% 3.77
Fibonacci 38.2% 3.22
52-Week Low 1.41

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar